A synthetic lethality player emerges in China, armed with lessons on undruggable oncogene from Nobel laureate's lab
As a longtime postdoc in the UCSF lab of Michael Bishop — the Nobel laureate known, among other things, for cloning the oncogene MYC — Dun Yang knew the cancer target like an archer knows the bullseye.
“I always talk about if we needed to nominate the most important oncogene […] that should be MYC,” he told Endpoints News. “The second one would be RAS. Because more than 50% of human cancer overexpress MYC oncogene.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.